For CRC, it is important to determine all of the RAS mutations including mutations in the Kirsten RAS (KRAS) gene at exon 2 (codon 12/13), exons 3 and 4, and neuroblastoma RAS (N-RAS) mutations at exons 2–4 [19]. The gene discussed is KRAS; the disease is colorectal carcinoma.